Wesana Health Holdings Inc. (WSNAF)
Market Open
12 Dec, 20:00
OTC PINK OTC PINK Primary $
0. 01
-0
-27.54%
$
526.16K Market Cap
- P/E Ratio
0% Div Yield
1,220 Volume
- Eps
$ 0.01
Previous Close Day Range
0.01 0.01
Year Range
0 0.15
Want to track WSNAF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
WSNAF trading today lower at $0.01, a decrease of 27.54% from yesterday's close, completing a monthly decrease of -50% or $0.01. Over the past 12 months, WSNAF stock lost -33.33%.
WSNAF is not paying dividends to its shareholders.
The last earnings report, released on Nov 27, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
WSNAF Chart
Wesana Health Holdings Inc. (WSNAF) FAQ
What is the stock price today?
The current price is $0.01.
On which exchange is it traded?
Wesana Health Holdings Inc. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is WSNAF.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 526.16K.
Has Wesana Health Holdings Inc. ever had a stock split?
No, there has never been a stock split.
Wesana Health Holdings Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Daniel Carcillo CEO | OTC PINK Exchange | CA95081C1059 ISIN |
| US Country | 7 Employees | - Last Dividend | 10 May 2021 Last Split | - IPO Date |
Overview
Wesana Health Holdings Inc., based in Chicago, Illinois, is a company currently not engaged in significant operations. Previously, the company focused on developing evidence-based formulations and protocols aimed at helping patients overcome a variety of neurological, psychological, and mental health issues stemming from trauma. However, the description indicates a pivot away from these activities, leaving the company's current operational status and future direction open-ended.
Products and Services
Previously, Wesana Health was involved in the development of several key offerings aimed at addressing trauma-related ailments:
- Evidence-Based Formulations: Wesana Health was working on the creation of medically and scientifically supported formulations. These products were designed to target and alleviate symptoms associated with neurological and psychological conditions. The objective was to base these treatments on rigorous research to ensure their efficacy and safety for patients.
- Protocols for Patient Empowerment: Alongside its formulations, the company developed specific protocols. These were structured programs or treatment plans that guided patients on how to use the formulations effectively. The aim was to empower patients with the knowledge and resources to actively participate in their own recovery and overcome mental health, psychological, and neurological issues related to trauma.
Contact Information
Address: 433 W Van Buren Street
Phone: 773 236 7972
Website: https://www.wesanahealth.com
2025 © Marketlog. All Rights Reserved.
